I E Smith, T J McElwain. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentAdultChildCytarabine/administration & dosageCytarabine/therapeutic useDaunorubicin/therapeutic useDose-Response Relationship, DrugDoxorubicin/administration & dosageDoxorubicin/therapeutic useDrug SynergismDrug Therapy, CombinationHumansInfusions, ParenteralInjections, IntravenousLeukemia, Myeloid, Acute/drug therapyMiddle AgedRemission, Spontaneous
Substances: See more » CytarabineDoxorubicinDaunorubicin
Year: 1974 PMID: 4135524 DOI: 10.1016/s0140-6736(74)91589-x
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321